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Abstract. 
The widespread unregulated use of antibiotics without medical consultation contributes to the burden of 
antibiotic resistance in Southeast Asian countries. This study investigated antibiotic use before hospital 
consultation. In a prospective observational study from February 2, 2015, to July 2, 2015, we enrolled febrile 
patients attending the emergency room in San Lazaro Hospital, Manila, the Philippines. A urine sample was 
collected and a bioassay was used to detect antibiotic activity in urine using Bacillus stearothermophilus 
(ATCC7953), Escherichia coli (ATCC25922), and Streptococcus pyogenes (ATCC19615). Patients or 
caregivers reported their medication history, clinical information, and socioeconomic status. During the study 
period, 410 patients were enrolled. The median (interquartile range) age was 14 (7–23) years and 158 (39%) 
reported prior antibiotic use, predominantly a beta-lactam antibiotic. A total of 164 (40%, 95% confidence 
interval [CI]: 35–45) patients were urine bioassay positive with any of three organisms. The Bacillus assay was 
the most sensitive, detecting 162 (99%, 95% CI: 96–100) cases. Among bioassay positive patients, dengue (N = 
91, 55%, 95% CI: 48–63) was the most frequent diagnosis, followed by other viral infections, including 
measles, rubella, and mumps (N = 17, 10%, 95% CI: 6–16). Patients with a positive bioassay were significantly 
more likely to be from the lowest-income group (adjusted odds ratio [AOR]: 1.7; 95% CI: 1.1–2.6) and required 
hospital admission (AOR: 2.1; 95% CI: 1.3–3.5). Unnecessary antibiotic use for febrile illnesses before hospital 
consultation is common in a low-income, highly populated urban community in Manila. Education targeting this 
group should be implemented to reduce unnecessary antibiotic use. 
INTRODUCTION 
Antibiotic resistance is a major public health problem worldwide.
1
 The rapid emergence 
and spread of antibiotic resistance have been reported in many countries.
2,3
 Infections with 
antibiotic resistant organisms are associated with higher mortality, prolonged illness, and 
increased health-care costs because of additional diagnostic tests and antibiotic therapies.
4,5
 
Unregulated use of antibiotics is common in many resource-limited countries and one of the 
factors contributing to the high prevalence of antibiotic resistance.
1,6,7
 
In the Philippines, despite the existing legislative framework to control antibiotic use, the 
unregulated sale of antibiotics without medical prescription is widespread.
8,9
 Even those with 
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a low-income can afford to purchase low-priced generic antibiotics without a medical 
consultation. People may prefer antibiotics over the counter because of the possible 
additional costs, efforts, and time incurred when visiting health facilities.
9
 The widespread 
use of antibiotics before medical consultation can result in a significantly lower yield of the 
causative pathogen in microbiology tests.
10,11
 This can lead to misdiagnosis, delay of proper 
treatment, and poor surveillance of resistance. 
Understanding the prevalence of community antibiotic use is useful information for 
providing a more appropriate medical management in health care facilities and for developing 
stewardship strategies to control resistance in the community. Several studies have shown 
that self-reporting by patients or caregivers about the history of recent antibiotics can be 
unreliable.
12
 Laboratory bioassay methods have been used to detect antibiotic activity in body 
fluid specimens as a measure of antibiotic use.
13,14
 Relatively high rates of antibiotic use 
detected by the bioassay have been reported in Southeast Asia.
15–17
 Limited information is 
available on the prevalence of antibiotic use before medical consultation in low-income 
communities in the Philippines. We conducted a prospective hospital-based observational 
study investigating prior antibiotic use in patients attending the San Lazaro Hospital (SLH) 
for a medical consultation. 
MATERIALS AND METHODS 
Setting. 
We performed a prospective observational study, in single health facility in Manila City, 
Metro Manila (officially called as National Capital Region), the Philippines. The SLH is a 
500-bed tertiary hospital specializing in infectious diseases. This national government 
hospital is the National Infectious Disease Referral Center and is also a major care provider 
for people from the low-income area in Manila city. This hospital is located in one of the 
most economically depressed and densely populated districts in the country. Although SLH is 
a tertiary care referral hospital, most outpatients in the emergency room (ER) are walk in and 
live around the hospital. 
Patients. 
This study was conducted each weekday between 9 AM and 4 PM from February 2, 2015  
to July 2, 2015. All patients aged more than 12 months who presented with fever or a history 
of fever with onset within the last 2 weeks were enrolled during the recruitment period. 
Subjects aged less than 12 months , previously diagnosed with human immunodeficiency 
virus (HIV), with on-going treatment of tuberculosis (TB), or a history of hospital admission 
within the previous month were excluded. Subjects unable to provide urine were also 
excluded from this study. 
Samples and data. 
After providing written informed consent, sociodemographic and clinical information of 
the patient or patient’s caregiver were collected using a standard questionnaire. 
Socioeconomic information included area of residence and patient’s or caregiver’s monthly 
income. The clinical diagnosis made by the attending physician, the physical examination 
findings, antibiotic use during this illness, and the name of antibiotics were documented by 
the researcher. Urine samples were collected before the initiation of antibiotics in the 
hospital. The samples were promptly transported to the laboratory for aliquoting and storage 
in a 80°C freezer until later testing in the bioassay. Twenty urine samples of healthy 
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volunteers with no history of consumption of any antibiotics within the previous 2 weeks 
were also obtained as negative controls. 
Laboratory methods. 
A disc diffusion method, as previously described by Liu et al.,
18
 was used to measure 
antibiotic activity in the urine samples. Three indicator organisms prepared to a 0.5 
Macfarland concentration were inoculated on agar in Petri dishes. Mueller-Hinton agar was 
used for the Bacillus stearothermophilus (ATCC 7953) and Escherichia coli (ATCC 25922), 
Mueller-Hinton agar with 5% sheep blood was used for Streptococcus pyogenes (ATCC 
19615). Three microliters of urine was applied to 6-mm diameter discs of sterile filter paper 
which had been placed on the lawns of each organism. The plates of S. pyogenes and E. coli 
were incubated at 35°C and at 56°C for B. stearothermophilus for 18–24 hours. After 
incubation, the zone diameter of inhibited bacterial growth surrounding each filter paper disc 
was measured. 
Data analysis. 
Statistical analysis of patient characteristics and urine bioassay result was conducted 
using the 2 test or Fisher’s exact test for categorical variables and the t test for numerical 
variables. To investigate the effect of various variables on prior antibiotic use and 
hospitalization as required by the attending physician, an unadjusted and adjusted logistic 
regression model was used. Adjusted models included values for age group (1–4, 5–18, 
19–64, 64 over years old), sex, duration of symptom, living area, and symptoms which were 
significant relation with the urine bioassay result. Data were managed using Microsoft 
Access, and statistical analyses were performed using the Stata software (Stata Statistical 
Software Release 13; Stata Corp., College Station, Texas). Values of P < 0.05 were 
considered significant. 
Ethical consideration. 
All participants, or for children their parent or guardian, were asked to give informed 
written consent at the time of enrollment. Ethical approval was obtained from the Research 
and Ethical Review Board of SLH, the Philippines, and the Institutional Review Board of the 
Institute of Tropical Medicine, Nagasaki University, Japan. 
RESULTS 
The total number of patient consultations in the ER was 8,375 during the study period. 
One thousand three hundred and twenty three patients visited from Monday to Friday 
between 9 AM and 4 PM. Among them, 545 subjects were excluded because the reason for 
consultation was after an animal bite (N = 53), they were being treated for TB or HIV (N = 
21), aged less than 1 year (N = 85), not a febrile illness (N = 361), and refused (N = 9) and 
were unable to provide urine (N = 16). Among possibly eligible subjects, 410 (53%) patients 
agreed to be enrolled in this study. For organizational reasons, the remaining 368 patients 
were not seen by the study team. The examination of the ER ledger for these patients 
revealed that some may have been eligible for the study but it was not possible to determine 
the exact number. 
The urine bioassay was positive for antibiotic activity for any of the three organisms in 
164 (40%, 95% confidence interval [CI]: 35–45) samples. One hundred and sixty two (99%, 
95% CI: 96–100) of the positive samples were detected by the plates with B. 
stearothermophilus. The plates with E. coli and S. pyogenes detected 85 (52%, 95% CI: 
44–60) and 120 (73%, 95% CI: 66–80) of any positive assay, respectively. Although the 
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assay of S. pyogenes was not able to detect further cases additional with B. 
stearothermophilus, the assay of E. coli showed further two cases (1.2%, 95% CI: 0.1–4). 
According to the self-reports, in these two additional cases co-trimoxazole and ciprofloxacin 
had been taken. None of the 20 healthy volunteers had antibiotic activity detected in their 
urine. 
Table 1 shows the relationship between patient antibiotic use based on self-reports and 
the bioassay. The urine bioassay showed 122 (80.8%, 95% CI: 73.6–86.7) positive urine 
assays among subjects who reported to take antibiotics during the illness. There were 42 
(16.2%, 95% CI: 11.9–21.3) positive urine assays among subjects who reported not taking 
antibiotics and 29 (19.2%, 95% CI: 13.2–26.4) subjects who reported antibiotic use but 
showed a negative urine assay. The positive predicted value and negative predict value of 
self-reports were 80.8% and 83.8%, respectively. 
According to patients’ self-reporting, the main source of antibiotics was community 
pharmacies followed by private clinics and public health centers (Tables 2 and 3). None of 
the patients reported obtaining medication from friends, relatives, or charities. Most 
antibiotics were beta-lactams including amoxicillin, cloxacillin, amoxicillin/clavulanate, and 
oral cephalosporins. The usage of fluoroquinolones was small (8%). Most of the patients took 
antibiotics for less than 7 days (91%). 
Dengue fever was most the common clinical diagnosis among enrolled patients (N = 200, 
48.8%, 95% CI: 43.8–53.7) and patients with positive urine bioassay (N = 91, 55.5%, 95% 
CI: 47.5–63.2). This was followed by other viral infection, such as measles, rubella,  mumps 
(N = 17, 10.4%, 95% CI: 6.2–16.1), upper respiratory infection (N = 14, 8.5%, 95% CI: 
4.7–13.9), and acute gastroenteritis (N = 14, 8.5%, 95% CI: 4.7–13.9). 
The association between the characteristics of enrolled patients and the urine bioassay 
results is shown in Table 4. There was no significant difference in the age group, sex, and the 
living area between the subjects with the positive and negative result. Patients presenting with 
a rash were less likely to have a positive urine bioassay but patients presenting with 
abdominal pain or arthralgia were more likely to have a positive result. A longer duration of 
symptoms was observed in patients with a positive urine bioassay. Significant differences in 
the proportion with a positive bioassay were observed between the low income group 
(income < 5,000 Philippine pesos [PHP]/month) and the higher income group (income  
5,000 PHP/month) (adjusted odds ratio [AOR]: 1.78; 95% CI: 1.17–2.72). Furthermore, a 
higher risk of subsequent admission from the ER was observed among patients who had 
taken antibiotics before their consultation as indicated by a positive urine bioassay 
(unadjusted odds ratio [OR]: 2.50; 95% CI: 1.56–4.00, AOR: 1.96; 95% CI: 1.17–3.29; Table 
5). 
DISCUSSION 
This study, using an objective urinary bioassay, has demonstrated that a high proportion 
of people used antibiotics before hospital consultation in a low-income urban population in 
the Philippines. According to the diagnosis by the attending physician in the hospital, dengue 
was by far the most common diagnosis and most antibiotics were unnecessary. 
Our study found that a substantial proportion of patients/caregivers reported taking the 
antibiotics which were purchased in a local pharmacy. We were unable to identify whether 
the purchases were based on the doctor’s prescription. We assume that certain proportion of 
our enrolled subjects purchased antibiotics without medical consultation or prescription. In 
the Philippines, although a medical prescription is officially required to obtain antibiotics, 
Page 5 of 14 
recent reports indicate that inappropriate selling of antibiotics without prescription occurs in 
community drug stores.
9
 
We found a significant association between the monthly income of patients and a positive 
urine bioassay result. The average income per month in the Philippines is about 9,449 
Philippine Peso which is equivalent to 215 US dollars.
19
 The economic status of our studied 
population was lower than this average. In Manila, inexpensive generic antibiotics are widely 
available.
8,9
 We recently visited three local community pharmacies where antibiotics were 
available without a prescription and generic antibiotics were available at low cost: 
amoxicillin/capsule (500 mg) 5.5–6.6 PHP (0.11–0.13 US dollar); 
amoxicillin/clavulanate/tablet (500/125 mg) 25–50 PHP (0.5–1 US dollar); 
trimethoprim-sulfamethoxazole/tablet (800/160 mg) 5–10 PHP (0.1–0.2 US dollar); and 
levofloxacin/tablet (500 mg) 25–45 PHP (0.5–0.9 US dollar). Although most public health 
clinics provide free medical consultation and drugs, we speculate that patients/caregivers 
obtain antibiotics in their local pharmacies because they might consider the higher cost in 
medical facilities than the cost in the pharmacy due to their poor knowledge. Long waiting 
time in health facilities is also considered to be another factor leading people to go to the 
pharmacy without medical consultation in Manila. 
A few other studies have described a relationship between economic status and antibiotic 
use.
20,21
 The opposite result from our finding was observed in Nigeria that children with a 
higher socioeconomic status were more likely to have consumed antibiotics before the 
consultation to tertiary hospitals.
22
 The authors of this study suggested that children living in 
a higher-economic status area tended to go to private clinics which were more likely to 
prescribe antibiotics. In our setting, most patients attending this hospital had a low-income 
and, in contrast with the study in Nigeria, there were very few with a high-income. There 
may also be a relationship between low economic status and low educational attainment 
although our study did not determine the educational level of subjects. A study in Albania 
found that people with low education level were more likely to use antibiotics without 
prescription.
23
 These results suggested that to reduce unnecessary antibiotic use, it is 
important to provide knowledge and education about acute febrile illness targeting the 
low-income group. 
Studies about antibiotic use before the medical consultation using a laboratory bioassay to 
detect antibiotic activity in a body fluid have been conducted in various settings (Table 6). 
The inclusion criteria in these studies and their target population have varied (e.g., children or 
adults, outpatients or inpatients, and febrile or all patients).
11,12,15–18,22,24–33
 In view of the 
different inclusion criteria it is difficult to compare the antibiotic use in different settings. 
Furthermore, the various types of body fluid specimen and indicator organisms were used in 
each study. The results of antibiotic use reported by previous studies have varied between 
20% and 80% (Table 6). Recent studies in Cambodia and Laos using a urine bioassay method 
similar to ours showed that 32% and 50% of outpatients had urinary antibiotic activity, 
respectively.
15,16
 Our prevalence of urine antibiotic activity (40%, 95% CI: 34–47) was 
similar to these results from Southeast Asian countries. We observed a higher level of 
agreement between self-reported antibiotic use and antibiotic activity detected in the urine 
than those of other previous reports (Table 6). Among patients/caregivers who reported 
taking antibiotics before their medical consultation, our urine assay detected antibiotic 
activities in 80.8% (95% CI: 67–96). Most patients enrolled in our study were able to name 
the antibiotic they had used. A previous study study conducted in the Philippines in 1980s 
showed a significant gap between the self-reports and evidence of antibiotic activity.
28
 The 
results of our current study suggest that the self-reporting of antibiotic use was relatively 
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reliable in this area and that people have awareness of their antibiotic use at a community 
level. 
Significant relationships between antibiotic use and some symptoms were found. While 
patients who had abdominal pain or arthralgia were more likely to take antibiotics before 
medical consultation, patients presenting with a rash were less likely to take antibiotics. This 
may be because patients/caregiver tend to consider that a rash indicates a serious condition 
that should be seen at a hospital whereas abdominal pain or arthralgia may be considered less 
serious and for which antibiotics may be taken without medical consultation. Abdominal pain 
is a common symptom in dengue patients and one of the important warning signs.
34
 Because 
dengue fever is a very common infectious disease in Philippines and antibiotic use is not 
necessary, these factors suggested that the education for people who had abdominal pain is 
also necessary in dengue endemic area. 
Several different bacteria have been used as indicator organisms in the urinary bioassay. 
Almost 99% of positive samples in this study were detected using B. stearothermophilus. 
Similar findings were obtained in studies in Cambodia and Laos.
15,16
 It is possible the assay 
process could be simplified by using only one organism. This will depend on the local pattern 
of antibiotic use; fluoroquinolones, not commonly used in these three settings but common in 
others, may not be reliably detected using B. stearothermophilus.
15,16
 
There are several limitations in our study. We calculated that only 53% of potentially 
eligible patients agreed to participate in the study. This was based on the examination of the 
ER ledger for patients we missed being able to approach. We could not be sure that the 
missed patients would have been eligible, but this did introduce a probable selection bias. The 
study period was only during the daytime and in the dry season. During the rainy season in 
the Philippines, the number of consultation increases due to dengue fever, leptospirosis, and 
acute gastritis. Thus, the study may not be fully representative of febrile patients seen at the 
ER in the SLH. Our study subjects were mainly drawn from a low-economic status 
population, did not include middle and high income participants, and therefore may not be a 
representative of community antibiotic use in a fully representative population in the 
Philippines. The urine bioassay could underestimate antibiotic use as it may only detect some 
antibiotics, such as beta-lactams and erythromycin, for 12–24 hours after taking a single 
dose.
32
 We did not determine the timing of antibiotic exposure in relation to the time of the 
urine sample which might have added more precision to our estimates. Moreover, antibiotics, 
such as chloramphenicol and doxycycline, are predominantly metabolized by the liver with 
only a small proportion of antibiotic excreted in the urine.
13
 According to self-reports of 
antibiotic use in our enrolled subjects, the use of these antibiotic was uncommon. Freezing 
and thawing of the urine sample may have led to a loss of antibiotic activity. False positive 
results may occur due to other agents present in the urine exerting antibacterial activity.
16
 
Recall bias by the patient/caregiver may lead to an inaccurate measure of self-reported 
antibiotic consumption. We were also unable to confirm the diagnosis of enrolled patients 
which were relied on clinical diagnosis by the attending physicians in the SLH. 
CONCLUSION 
This study, conducted in a densely populated, low-income, and dengue endemic area in 
Manila, provides further evidence that a significant proportion of patients presenting to 
hospital with fever have already taken antibiotics. Interestingly the lowest-income group was 
more likely to use antibiotics compared with other groups. Further studies are needed to 
clarify the impact of education about proper implementations for acute febrile illness to 
reduce unnecessary antibiotic use targeting on low-income population. 
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TABLE 1 
Relationship between patients self-reported antibiotic use and urine bioassay results 
Self-reported antibiotic use Positive urine bioassay Negative urine bioassay 
N = 144 N = 246 
n (%) n (%) 
Yes N = 151 122 (80.8) 29 (19.2) 
No N = 259 42 (16.2) 217 (83.8) 
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TABLE 2 
Characteristics of the self-reported antibiotic use and the proportion with antibiotics detected and not deteceted 
by urine bioassay 
  Self-reported  
n (%) 
Urine 
antibiotic 
activity 
detected  
n (%) 
Urine 
antibiotic 
activity not 
detected  
n (%) 
P value* 
Total  151 (36.8) 122 (80.8) 29 (19.2) – 
Source of antibiotic     
 Pharmacy 91 (60.3) 70 (57.4) 21 (72.4) 0.454 
 Private clinic 25 (16.6) 21 (17.2) 4 (13.8) 
 Public health center 22 (14.6) 20 (16.4) 2 (6.9) 
 Hospital 13 (8.6) 11 (9.0) 2 (6.9) 
Antibiotic taken     
 Amoxicillin 35 (23.2) 28 (23.0) 7 (24.1) 0.081 
 Cloxacillin 25 (16.6) 22 (18.0) 3 (10.3) 
 Amoxicillin/clavulanate 24 (15.9) 20 (16.4) 4 (13.8) 
 Oral cephalosporins 12 (8.0) 12 (9.8) 0 (0) 
 Co-trimoxazole 18 (11.9) 14 (11.5) 4 (13.8) 
 Fluoroquinolones 8 (5.3) 5 (4.1) 3 (10.3) 
 Macrolide 3 (2.0) 2 (1.6) 1 (3.5) 
 Chloramphenicol 2 (1.3) 0 (0.0) 2 (6.9) 
 Metronidazole 2 (1.3) 1 (0.8) 1 (3.5) 
 Others 4 (2.7) 4 (3.3) 0 (0) 
 Unknown 18 (11.9) 14 (11.5) 4 (13.8) 
Duration of antibiotics     
 1 day 49 (32.5) 38 (31.2) 11 (37.9) 0.016 
 2–3 days 64 (42.4) 55 (45.1) 9 (31.0) 
 4–6 days 23 (15.2) 21 (17.2) 2 (6.9) 
 More than 1 week 15 (9.9) 8 (6.6) 7 (24.1) 
Living area     
 Manila city 64 (42.4) 51 (41.8) 13 (44.8) 0.943 
 Metro Manila but outside Manila city 72 (47.7) 59 (48.4) 13 (44.8) 
 Outside Metro Manila 15 (9.9) 12 (9.8) 3 (10.3) 
Monthly income (PHP)†     
  5,000 56 (37.1) 43 (32.3) 13 (44.8) < 0.05 
 < 5,000 95 (62.9) 79 (64.8) 16 (55.2) 
* Pearson’s 2 test, comparing mean between urine bioassay positive and negative. 
† PHP = Philippines peso (100 PHP = 2 US dollar). 
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TABLE 3 
Clinical diagnosis at emergency room in the San Lazaro Hospital and the results of urine antibiotic bioassay 
 Total Urine antibiotic 
activity detected 
N = 410 N = 164 
n (%) n (%) 
Dengue 200 (48.8) 91 (55.5) 
Upper respiratory infection 31 (7.6) 14 (8.5) 
Lower respiratory infection 27 (6.6) 7 (4.2) 
Acute gastroenteritis 27 (6.6) 14 (8.5) 
Urinary tract infection 15 (3.7) 3 (1.8) 
Other viral infection (including measles, rubella, 
mumps) 
79 (19.3) 17 (10.4) 
Enteric fever 7 (1.7) 4 (2.4) 
Soft tissue infection 2 (0.5) 2 (1.2) 
Others 19 (4.6) 11 (6.7) 
Unknown 3 (0.7) 1 (0.6) 
TABLE 4 
Associations between patient characteristics and the urine bioassay result 
 Urine bioassay result   
 Negative  
n (%) 
Positive  
n (%) 
Unadjusted OR 
(95% CI) 
AOR*  
(95% CI) 
Overall 246 (60.0) 164 (40.0) – – 
Sex (male) 139 (56.5) 104 (63.1) 1.33 
(0.89–2.00) 
1.35 (0.88–2.08) 
Age group (years old)     
 1–4 93 (37.8) 59 (36.0) Ref Ref 
 5–18 42 (17.1) 19 (11.6) 0.71 
(0.38–1.34) 
0.90 (0.45–1.81) 
 19–64 110 (44.7) 82 (50.0) 1.18 
(0.76–1.81) 
1.30 (0.81–2.08) 
 64 over 1 (0.4) 4 (2.4) 6.31 
(0.69–57.8) 
8.12 (0.82–80.81) 
Symptom     
 Cough 117 (47.6) 88 (53.7) 1.28 
(0.86–1.90) 
– 
 Headache 161 (65.5) 110 (67.1) 1.08 
(0.71–1.63) 
– 
 Sputum 82 (33.3) 67 (40.9) 1.38 
(0.92–2.08) 
– 
 Runny nose 74 (30.1) 59 (36.0) 1.31 
(0.86–1.99) 
– 
 Sore throat 77 (31.3) 52 (31.7) 1.02 
(0.67–1.56) 
– 
 Dyspnea 70 (28.5) 52 (31.7) 1.17 
(0.76–1.79) 
– 
 Abdominal pain† 110 (44.7) 91 (55.5) 1.54 
(1.04–2.29) 
1.40 (0.91–2.15) 
 Diarrhea 27 (11.0) 24 (14.6) 1.39 
(0.77–2.51) 
– 
 Rash† 103 (41.9) 48 (29.3) 0.57 
(0.38–0.88) 
0.59 (0.38–0.93) 
 Myalgia 92 (37.4) 62 (37.8) 1.02 
(0.68–1.53) 
– 
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 Arthralgia† 87 (35.4) 75 (45.7) 1.54 
(1.03–2.31) 
1.59 (1.01–2.51) 
Mean duration of 
symptom (days)‡ 
4.3 5.1 1.11 
(1.03–1.19) 
1.11 (1.03–1.20) 
Living area     
 Manila city 116 (47.2) 72 (43.9) Ref Ref 
 Metro Manila but 
outside Manila city 
104 (42.3) 78 (47.6) 1.21 
(0.80–1.83) 
1.13 (0.72–1.77) 
 Outside Metro 
Manila 
26 (10.6) 14 (8.5) 0.87 
(0.47–1.77) 
0.59 (0.27–1.31) 
Monthly income (PHP)†   
  5,000 123 (50.0) 57 (34.8) Ref Ref 
 < 5,000 123 (50.0) 107 (65.2) 1.88 
(1.25–2.82) 
1.75 (1.15–2.68) 
AOR = adjusted odds ratio; CI = confidence interval; OR = odds ratio; PHP = Philippines peso (100 PHP = 2 
US dollar); Ref = reference. 
* Adjusted for age group, sex, duration of symptom, living area, presence of rash, presence of abdominal pain, 
presence of arthralgia, and monthly income group. 
† P < 0.05 by Pearson’s 2 test, comparing proportion between urine bioassay positive and negative group. 
‡ P < 0.05 by t test, comparing mean between urine bioassay positive and negative group. 
TABLE 5 
Associations between patient characteristics on admission, the urine bioassay result and the patients that 
required hospitalization 
  Required hospitalization 
to SLH 
  
  No Yes Unadjusted AOR*  
(95% CI) n (%) n (%) OR (95% CI) 
Total 122 (29.8) 287 (70.2) – – 
Sex (male) 71 (58.2) 172 (59.9) 1.07 (0.70–1.65) 1.04 (0.64–1.70) 
Age group 
 1–4 38 (31.2) 113 (39.4) Ref Ref 
 5–18 19 (15.6) 42 (14.6) 0.74 (0.69–1.43) 1.21 (0.54–2.71) 
 19–64 64 (52.5) 128 (44.6) 0.67 (0.42–1.08) 0.76 (0.43–1.33) 
 65 over 1 (0.8) 4 (1.4) 1.35 (0.15–12.40) 0.90 (0.80–10.15) 
Presence of symptoms during the febrile illness 
 Cough 61 (50.0) 144 (50.2) 1.01 (0.66–1.54) – 
 Headache 77 (63.1) 193 (67.3) 1.20 (0.77–1.87) – 
 Sputum 47 (38.5) 102 (35.5) 0.88 (0.57–1.36) – 
 Runny nose 44 (36.1) 89 (31.0) 0.80 (0.51–1.24) – 
 Sore throat 41 (33.6) 88 (30.7) 0.87 (0.56–1.37) – 
 Dyspnea 30 (24.6) 92 (32.1) 1.45 (0.89–2.34) – 
 Abdominal pain† 40 (32.8) 160 (55.8) 2.58 (1.65–4.03) 2.11 (1.28–3.47) 
 Diarrhea† 5 (4.1) 46 (16.0) 4.46 (1.73–11.53) 5.85 (1.94–17.60) 
 Rash 47 (38.5) 104 (36.2) 0.91 (0.59–1.40) – 
 Myalgia† 31 (25.4) 122 (42.5) 2.17 (1.36–3.47) 1.52 (0.84–2.76) 
 Arthralgia† 31 (25.4) 130 (45.3) 2.43 (1.52–3.89) 2.01 (1.14–3.56) 
Duration of symptom (mean 
days)‡ 
3.7 5 1.26 (1.12–1.41) 1.23 (1.09–1.38) 
Comorbidity§ 28 (23.1) 54 (18.8) 1.26 (1.12–1.41) 0.84 (0.47–1.50) 
Living area†     
 Manila city 73 (59.8) 114 (39.7) Ref Ref 
 Metro Manila but 
outside Manila city 
40 (32.8) 142 (49.5) 2.27 (1.44–3.59) 2.29 (1.43–3.66) 
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 Outside Metro 
Manila 
9 (7.4) 31 (10.8) 2.21 (0.99–4.90) 1.63 (0.70–3.76) 
Monthly income (PHP)    
  5,000 61 (50.0) 119 (41.5) Ref – 
 < 5,000 61 (50.0) 168 (58.5) 1.41 (0.92–2.16) – 
Prehospital antibiotic use confirmed by urine bioassay†  
  31 (25.4) 132 (50.0) 2.50 (1.56–4.00) 1.99 (1.17–3.39) 
AOR = adjusted odds ratio; CI = confidence interval; OR = odds ratio; PHP = Philippines peso (100 PHP = 2 
US dollar); Ref = reference; SLH = San Lazaro hospital. 
* Adjusted for age group, sex, duration of symptom, living area, presence of any comorbidity, presence of 
abdominal pain, presence of diarrhea, presence of myalgia, presence of arthralgia, rash. 
† P < 0.05 by Pearson’s 2 test, comparing proportion between patients required to be admitted to SLH and 
those who was not required. 
‡ P < 0.05 by t test, comparing mean between patients required to be admitted to SLH and those who were not 
required. 
§ Subjects who have a comorbidity were defined as patients who had taken regular medicine for chronic 
diseases. 
TABLE 6 
Previous studies analyzing antibiotic use before medical consultation using a bioassay to measure antibiotic use 
Study site Bioas
say 
samp
le 
Year Target 
population 
Criteria Num
ber 
teste
d 
Repor
ting 
antibi
otic 
use 
(%) 
Positive 
bioassay 
(%) 
Bacteria used in the 
laboratory assay 
Philippine
s
28
 
Seru
m 
1984–
1986 
Children < 5 
years 
ALRI 530 51.6 27.9 Streptococcus aureus 
Urine 1984–
1986 
Children < 5 
years 
ALRI 346 NR 32.3 S. aureus 
Uruguay
27
 Urine 1987–
1988 
Children < 5 
years 
ALRI 90 NR 64.4 Bacillus megaterium 
Philippine
s
12
 
Urine 1989–
1990 
Children < 5 
years 
ALRI 108 55 84 S. aureus 
Argentina
2
5
 
Urine NR* Children < 5 
years 
ALRI 424 40 72 Bacillus subtilis 
Kenya
24
 Urine 1994–
1996 
Adults ALRI 248 NR 54 S. aureus 
Kenya
31
 Plas
ma 
1998–
2002 
Children ( 
13 y/o) 
All admitted 
patients 
16,57
0 
NR 3.5–11‡ S. aureus 
Taiwan
18
 
Urine NR† Mainly 
adults 
All in ER 1,182 NR 55.2 Bacillus 
stearothermophilus, 
Streptococcus pyogenes, 
Escherichia coli§ 
Urine NR† Mainly 
adults 
All out 
patients 
203 NR 25.1 B. stearothermophilus, S. 
pyogenes, E. coli§ 
Nepal
17
 Urine 2001 Adults Febrile 
patients 
806 19 38 B. subtilis, S. pyogenes, E. 
coli 
Laos
16
 
Urine 2005 Children 
and adults 
Specific 
febrile illness
‖ 
2,058 NR 49.7 B. stearothermophilus, S. 
pyogenes, E. coli§ 
Urine 2005 Children 
and adults 
All out 
patients 
1,153 24 36.2 B. stearothermophilus, S. 
pyogenes, E. coli§ 
Thailand
30
 Seru 2005– Children Pneumonia NR¶ 27.3 23.6# S. aureus 
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m 2008 and adults and sepsis 
Multiple 
countries
33
** 
CSF 2006–
2007 
Children < 5 
years 
Meningitis 939 NR 33** Kocuria rhizophila 
Nigeria
22
 Seru
m 
2008–
2009 
Children < 5 
years 
Bacteraemia 126 NR 55.6 Micrococcus luteus 
Cambodia
15
 
Urine 2011 Children ( 
16 years/o) 
All out 
patients 
775 NR 31.7 B. stearothermophilus, S. 
pyogenes, E. coli§ 
Multiple 
countries
11
†† 
Seru
m 
2011–
2014 
Children < 5 
years 
Severe 
pneumonia 
3,995 NR 25.6†† S. aureus 
The 
Philippine
s (current 
study) 
Urine 2015 Children 
and adults 
ER attendees 
with fever 
410 36.8 40.0 B. stearothermophilus, S. 
pyogenes, E. coli§ 
ALRI = acute lower respiratory infection; ER = emergency room; HIV = human immunodeficiency virus; NR = 
not recorded. 
* Published 1990. 
† Published 1999. 
‡ 11% (fatal illness), 8.6% (severe illness), and 3.5% (non medical problems). 
§ B. stearothermophilus (ATCC 7953), S. pyogenes (ATCC 19615), and E. coli (ATCC 25922). 
‖ CNS infection, septicaemia typhus nonmalarial causes of fever. 
¶ 35,639 blood culture were taken. 
# 14% children < 5 years. 
** Pakistan 12% (Pakistan), 53% (Bangladesh), and 30–35% (African sites). 
†† Bangladesh (23.9%), Gambia (7.4%), Kenya (13.0%), Mali (19.2%), South Africa (HIV infected: 58.2%, 
HIV uninfected: 48.8%), Thailand (19.2%), and Zambia (HIV infected: 36.4%, HIV uninfected: 28.8%); 763 
(18.3%) enrolled subjects had antibiotic treatments in the study sites before the sample collections. 
